Genentech, Inc.
Clinical trials sponsored by Genentech, Inc., explained in plain language.
-
Experimental CAR T-Cell therapy takes on tough lupus cases
Disease control Not yet recruitingThis early-stage study tests a new treatment called P-CD19CD20-ALLO1 for people with severe lupus that hasn't improved with standard therapies. The treatment uses specially engineered immune cells to target and reduce harmful B cells. The study involves 162 adults aged 18-75 and …
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 09, 2026 05:20 UTC
-
New hope for advanced prostate cancer: experimental drug GDC-1261 enters human trials
Disease control Not yet recruitingThis study tests an experimental drug called GDC-1261 in people with advanced or metastatic prostate cancer that has worsened despite prior treatment. The main goals are to check the drug's safety and find the best dose. About 260 participants will take the drug, and researchers …
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated May 09, 2026 05:19 UTC